CELLULAR IMMUNE REACTION TO HUMAN MALIGNANT MELANOMA AND BREAST CARCINOMA CELLSCANEVARI S; FOSSATI G; DELLA PORTA G et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 56; NO 4; PP. 705-709; BIBL. 25 REF.Article

GENERATION OF MONOCLONAL ANTIBODIES REACTING WITH NORMAL AND CANCER CELLS OF HUMAN BREAST = GENERATION DES ANTICORPS MONOCLONAUX REAGISSANT AVEC LES CELLULES MAMMAIRES NORMALES ET MALIGNES CHEZ L'HOMMEMENARD S; TAGLIABUE E; CANEVARI S et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1295-1300; ABS. ENG; BIBL. 30 REF.; FIGArticle

IMMUNOCHEMICAL ANALYSIS OF THE DETERMINANT RECOGNIZED BY A MONOCLONAL ANTIBODY (MBR1) WHICH SPECIFICALLY BINDS TO HUMAN MAMMARY EPITHELIAL CELLS = ANALYSE IMMUNOCHIMIQUE DU DETERMINANT RECONNU PAR UN ANTICORPS MONOCLONAL (MBR1) QUI SE LIE DE FACON SPECIFIQUE AUX CELLULES EPITHELIALES MAMMAIRES HUMAINESCANEVARI S; FOSSATI G; BALSARI A et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1301-1305; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

HUMORAL CYTOTOXICITY IN MELANOMA PATIENTS AND ITS CORRELATION WITH THE EXTENT AND COURSE OF THE DISEASE. = LA CYTOTOXICITE HUMORALE CHES LES MALADES ATTEINTS DE MELANOME ET SA CORRELATION AVEC L'ETENDUE ET L'EVOLUTION DE LA MALADIECANEVARI S; FOSATI G; DELLA PORTA G et al.1975; INTERNATION. J. CANCER; SWITZ.; DA. 1975; VOL. 16; NO 5; PP. 722-729; ABS. FR.; BIBL. 1 P.Article

DELAYED CUTANEOUS HYPERSENSITIVITY REACTION TO CRUDE AND SEMIPURIFIED TUMOR EXTRACTS IN CANCER PATIENTSCANEVARI S; FOSSATI G; MIOTTI S et al.1981; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1981; VOL. 11; NO 1; PP. 81-85; BIBL. 14 REF.Article

CELLULAR IMMUNITY TO HUMAN BREAST CARCINOMA = IMMUNITE CELLULAIRE ENVERS LE CANCER DU SEIN CHEZ LA FEMMEFOSSATI G; CANEVARI S; DELLA PORTA G et al.1972; INTERNATION. J. CANCER,; SWITZ.; DA. 1972; VOL. 10; NO 2; PP. 391-396; ABS. FR.; BIBL. 8REF.Serial Issue

1975-1995 revised anti-cancer serological response : Biological significance and clinical implicationsCANEVARI, S; PUPA, S. M; MENARD, S et al.Annals of oncology. 1996, Vol 7, Num 3, pp 227-232, issn 0923-7534Article

Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicityCHINOL, M; CASALINI, P; SICCARDI, A. G et al.British journal of cancer. 1998, Vol 78, Num 2, pp 189-197, issn 0007-0920Conference Paper

CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinomaMAZZONI, A; MEZZANZANICA, D; JUNG, G et al.Cancer research (Baltimore). 1996, Vol 56, Num 23, pp 5443-5449, issn 0008-5472Article

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')₂ bispecific monoclonal antibodyNEGRI, D. R. M; TOSI, E; VALOTA, O et al.British journal of cancer. 1995, Vol 72, Num 4, pp 928-933, issn 0007-0920Article

Targeting of T lymphocytes against EGF-receptor⁺ tumor cells by bispecific monoclonal antibodies : requirement of CD3 molecule cross-linking for T-cell activationFERRINI, S; CAMBIAGGI, A; SFORZINI, S et al.International journal of cancer. 1993, Vol 55, Num 6, pp 931-937, issn 0020-7136Article

The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cellsCONDE, F. P; ORLANDI, R; CANEVARI, S et al.European journal of biochemistry (Print). 1989, Vol 178, Num 3, pp 795-802, issn 0014-2956Article

Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodiesMIOTTI, S; AGUANNO, S; CANEVARI, S et al.Cancer research (Baltimore). 1985, Vol 45, Num 2, pp 826-832, issn 0008-5472Article

ANTIBODY BINDING TO MEMBRANE OF CULTURED MELANOMA CELLS BY SERA OF MELANOMA PATIENTSCANEVARI S; FOSSATI G; VEZZONI P et al.1979; TUMORI; ITA; DA. 1979; VOL. 65; NO 1; PP. 51-64; ABS. ITA; BIBL. 32 REF.Article

Monoclonal antibodies by genetic engineering: novel reagents for in vivo diagnosis and therapyCANEVARI, S; FURLAN, D; MOSSA, A et al.The International journal of biological markers. 1993, Vol 8, Num 3, pp 147-150, issn 0393-6155Article

COMPLEMENT-DEPENDENT SERUM CYTOTOXICITY OF CANCER PATIENTS STUDIED BY ⁵¹CR RELEASE ASSAY ON HUMAN CANCER LINES.GARCIA PUCHE J; CANEVARI S; FOSSATI G et al.1977; TUMORI; ITAL.; DA. 1977; VOL. 63; NO 1; PP. 97-107; ABS. ITAL.; BIBL. 14 REF.Article

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodiesFIGINI, M; FERRI, R; MEZZANZANICA, D et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 12, pp 1018-1025, issn 0969-7128, 8 p.Article

Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19MANTOVANI, L. T; MIOTTI, S; MENARD, S et al.European journal of cancer. Part A. 1994, Vol 30, Num 3, pp 363-369Article

Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivoBOTTERO, F; TOMASSETTI, A; CANEVARI, S et al.Cancer research (Baltimore). 1993, Vol 53, Num 23, pp 5791-5796, issn 0008-5472Article

Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cellsALBERTI, S; FACHERIS, P; MANTOVANI, L et al.International journal of cancer. 1992, Vol 51, Num 3, pp 499-505, issn 0020-7136Article

Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18GADINA, M; CANEVARI, S; RIPAMONTI, M et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 4, pp 403-408, issn 0883-2897Conference Paper

The antitumor monoclonal antibody MOv2 recognizes the lewis A haptenLEONI, F; MAGNANI, J. L; MIOTTI, S et al.Hybridoma. 1988, Vol 7, Num 2, pp 129-139, issn 0272-457XArticle

Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancerLEONI, F; BAST, R. C. JR; CANEVARI, S et al.International journal of cancer. 1987, Vol 40, Num 5, pp 592-597, issn 0020-7136Article

Ricin A chain conjugated with monoclonal antibodies selectively killing human carcinoma cells in vitroCANEVARI, S; ORLANDI, R; RIPAMONTI, M et al.Journal of the National Cancer Institute. 1985, Vol 75, Num 5, pp 831-839, issn 0027-8874Article

Immunoconjugates : lessons from animal modelsCANEVARI, S; COLOMBATTI, M; COLNAGHI, M. I et al.Annals of oncology. 1994, Vol 5, Num 8, pp 698-701, issn 0923-7534Article